Normal function · from ai-gene-review (Q86WV6, commit 79fe13b38970) · AI-generated, not KB evidence

Stimulator of interferon genes protein (STING1/TMEM173) is a polytopic membrane protein of the endoplasmic reticulum and the central signalling adaptor of the cytosolic DNA-sensing pathway. Four transmembrane helices anchor it in the ER bilayer and support a cytosolic ligand-binding and signalling domain that forms an obligate dimer. STING1 is the receptor for 2'3'-cyclic GMP-AMP, the second messenger made by cGAS on detection of cytosolic DNA, and it also binds bacterial cyclic dinucleotides such as cyclic di-GMP directly, making it a sensor as well as an adaptor. Ligand binding closes the ligand-binding domain and rotates it relative to the transmembrane domain, driving side-by-side packing of dimers into tetramers and higher-order oligomers. Oligomerisation licenses COPII-dependent exit from the ER to the ER-Golgi intermediate compartment and the Golgi, where TBK1 is recruited and phosphorylates the STING1 C-terminal tail; phosphorylated STING1 then presents a docking surface for IRF3, which TBK1 phosphorylates to induce type I interferons. From post-Golgi endolysosomal compartments STING1 additionally activates NF-kappaB, a branch that can operate independently of interferon signalling, before being degraded in lysosomes. Oligomerisation and ER exit require membrane lipids as well as cGAMP: phosphatidylinositol 3,5-bisphosphate, made by PIKFYVE bound constitutively to STING1, together with cholesterol occupies a groove at the interface between adjacent dimers and acts as a molecular glue; phosphatidylinositol 4,5-bisphosphate binds the same site in vitro. Residue R71, which contacts the lipid 5-phosphate, is part of the common hypofunctional HAQ allele of human STING1. Independently of its adaptor role, the STING1 transmembrane domain conducts protons and deacidifies the Golgi, and this channel activity drives a separable output branch comprising non-canonical LC3B and GABARAP lipidation, inflammasome activation, and TFEB/TFE3-dependent lysosome biogenesis. Autophagy induction is independent of TBK1 and of interferon induction and is the evolutionarily older function of the pathway. Gain-of-function alleles cause the autoinflammatory disease SAVI, and chronic activation of the pathway contributes to senescence, age-related inflammation and neurodegeneration.

STING1 is the signal-transducing adaptor of the cytosolic DNA-sensing pathway. Binding of 2'3'-cGAMP or of bacterial cyclic dinucleotides to its cytosolic ligand-binding domain triggers high-order oligomerisation and ER exit; at the ERGIC and Golgi the oligomer recruits TBK1 through its C-terminal PXPLRXD motif, is phosphorylated on Ser366, and the phosphorylated tail then recruits IRF3 for TBK1-dependent phosphorylation, driving type I interferon transcription. From post-Golgi endolysosomes the same adaptor activity engages TRAF6 and activates NF-kappaB.
STING1 is the intracellular receptor for 2'3'-cGAMP. The mixed 2'-5'/3'-5' linkage of the endogenous cGAS product is bound with far higher affinity than other cyclic GMP-AMP isomers, and binding closes the lid of the ligand-binding domain to initiate the conformational change that leads to oligomerisation. The same pocket binds bacterial cyclic di-GMP directly (GO:0035438), so STING1 serves as a sensor of bacterial cyclic dinucleotides as well as a receiver of the host second messenger.
The STING1 transmembrane domain forms a proton-conducting pathway at the interface between protomers. Purified STING1 reconstituted into liposomes supports transmembrane proton transport, and in cells its activation raises Golgi pH. The resulting proton efflux drives an output branch that is separable from interferon induction: non-canonical LC3B and GABARAP lipidation, NLRP3 inflammasome activation, and relief of mTORC1 inhibition leading to TFEB/TFE3-driven lysosome biogenesis. The agonist C53 binds the channel interface and blocks flux, uncoupling these outputs from IRF3 signalling.
STING1 binds PtdIns(3,5)P2 through a groove formed at the interface between adjacent dimers, contributed by H16 and K20 of the N-terminal tail of one protomer and R71 of a neighbouring loop. Binding requires the full-length protein including the transmembrane domain, and is enhanced by cholesterol, which occupies an adjacent position in the same interface (GO:0015485). The lipid acts as a molecular glue that, together with cGAMP, stabilises high-order oligomers and thereby permits ER exit and TBK1 activation; PIKFYVE, the kinase that makes PtdIns(3,5)P2, is constitutively bound to STING1, and its deletion or mutation of the lipid-binding residues blocks trafficking and signalling. PtdIns(4,5)P2 occupies the same site in vitro. This is an activation requirement gating the adaptor function rather than an independent output, and it rests on companion papers from a single research programme.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
COPA Syndrome protective
mechanism: HAQ STING dominant suppression of STING signalling
STING-Associated Vasculopathy with Onset in Infancy untyped
Causative
mechanism: STING1 gain-of-function mutation
Leptospirosis no genetic record
mechanism: cGAS-STING-dependent type I interferon response
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.